APA

Huang X., Shipps G. W., Cheng C. C., Spacciapoli P., Zhang X., McCoy M. A., Wyss D. F., Yang X., Achab A., Soucy K., Montavon D. K., Murphy D. M. & Whitehurst C. E. (20140605). Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors. : ACS medicinal chemistry letters.

Chicago

Huang Xiaohua, Shipps Gerald W, Cheng Cliff C, Spacciapoli Peter, Zhang Xingmin, McCoy Mark A, Wyss Daniel F, Yang Xianshu, Achab Abdelghani, Soucy Kyle, Montavon Donna K, Murphy Denise M and Whitehurst Charles E. 20140605. Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors. : ACS medicinal chemistry letters.

Harvard

Huang X., Shipps G. W., Cheng C. C., Spacciapoli P., Zhang X., McCoy M. A., Wyss D. F., Yang X., Achab A., Soucy K., Montavon D. K., Murphy D. M. and Whitehurst C. E. (20140605). Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors. : ACS medicinal chemistry letters.

MLA

Huang Xiaohua, Shipps Gerald W, Cheng Cliff C, Spacciapoli Peter, Zhang Xingmin, McCoy Mark A, Wyss Daniel F, Yang Xianshu, Achab Abdelghani, Soucy Kyle, Montavon Donna K, Murphy Denise M and Whitehurst Charles E. Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors. : ACS medicinal chemistry letters. 20140605.